Effect of Carrier Excipient and Processing on Stability of Indorenate Hydrochloride/Excipient Mixtures

REFERENCES

• Hong E., Rión R., Nava-Felix P. Characterization of the Receptors Involved on the Central Antihipertensive Effect of TR 3369. Fed. Proc. 1980; 39: 963
   Google Scholar
• Benitez-King G., Chavez J.L., Martinez J., Benitez-King G., Antón-Tay F., Hong E. Further Evidence that Indorenate Hydrochloride is a 5-HT1 Agonist. Proc. West. Pharmacol. Soc. 1991; 34: 433–437
   PubMedGoogle Scholar
• Hong E., Villalón C.M. External Carotid Vasodilatation Induced by Serotonin and Indorenate Hydrochloride. Proc. West. Pharmacol. Soc. 1988; 31: 99–101
   PubMedGoogle Scholar
• Fernández-Guasti, Hong E., López-Rubalcava C. Species Differences in the Mechanism Through Which the Serotonergic Agonist Indorenate Hydrochloride Produce Their Anxiolitic Action. Psychopharmacology 1992; 107: 61–68
   PubMed Web of Science ®Google Scholar
• Benitéz-King G., Antón-Tay F., Hong E. Characterization of Indorenate Hydrochloride Effects on Brain Monoamine Metabolism. Drug Dev. Res. 1991; 23: 325–331
   Web of Science ®Google Scholar
• Carstensen J.T. Pharmaceutical Principles of Solid Dosage Forms. Technomic Publishing Co., PA, USA 1993; 15–31
   Google Scholar
• Russell J.L., Schwartz J.B. H. Lieberman, L. LachmanMixing. Pharmaceutical Dosage Forms: Tablets, . Marcel Dekker Inc., New York 1981; Vol. 2: 1–20
   Google Scholar
• Westerberg M., Nyström C. Physicochemical Aspects of Drug Release XVII. The Effect of Drug Surface Coverage to Carrier Materials on Drug Dissolution from Ordered Mixtures. Int. J. Pharm. 1993; 90: 1–17
   Web of Science ®Google Scholar
• Barra J., Falson-Rieg F., Doelker E. Influence of the Organization of Binary Mixes on Their Compactibility. Pharm. Res. 1999; 16(9)1449–1455
   PubMed Web of Science ®Google Scholar
• Carstensen J.T. Drug Stability. Principles and Practices. Marcel Dekker Inc., New York 1995; Vol. 2: 230–280
   Google Scholar
• Landín M., Casalderrey M., Martínez-Pacheco R., Gómez-Amoza J.L., Souto C., Concheiro A., Rowe R.C. Chemical Stability of Acetylsalicylic Acid in Tablets Prepared with Different Particle Size Fractions of a Commercial Brand of Dicalcium Phosphate Dihydrate. Int. J. Pharm. 1995; 123: 143–144
   Google Scholar
• Otzuka M., Kaneniwa N. Effect of Grinding on the Crystallinity and Chemical Stability in the Solid State of Cephalothin Sodium. Int. J. Pharm. 1990; 62: 65–73
   Google Scholar
• Hancock C., Zografi G. Characteristics and Significance of the Amorphous State in Pharmaceutical Systems. J. Pharm. Sci. 1997; 86: 1–12
   PubMed Web of Science ®Google Scholar
• Guo Y., Byrn S.R., Zografi G. Physical Characteristics and Chemical Degradation of Amorphous Quinapril Hydrochloride. J. Pharm. Sci. 2000; 89(1)128–143
   PubMed Web of Science ®Google Scholar
• List P.H., Müller B.W., Nürnberg E. Arzneiformenlehre. Wissenschaftliche Verlagsgesellschaft, Stuttgart, Germany 1980; Vol. 2: 33–35
   Google Scholar
• Villalobos-Hernández J.R., Arenas Hernández R., Villafuerte-Robles L. High-Performance Liquid Chromatography Assay for Indorenate Hydrochloride in Powder Mixtures. Drug Dev. Ind. Pharm. 2001; 27(1)39–45
   PubMed Web of Science ®Google Scholar
• Mura P., Manderioli A., Bramanti G., Furlanetto S., Pinzauti S. Utilization of Differential Scanning Calorimetry as a Screening Technique to Determine the Compatibility of Ketoprofen with Excipients. Int. J. Pharm. 1995; 119: 71–79
   Web of Science ®Google Scholar
• Wadke D.A., Seradjuddin A.T.M., Jacobson H. H.A. Lieberman, L. Lachman, J.B. SchwartzPreformulation Testing. Pharmaceutical Dosage Forms: Tablets, . Marcel Dekker Inc., New York 1967; Vol. 1: 48–51
   Google Scholar
• Jacobson H., Gibbs I. Differential Thermal Analysis as Screening Technique for Candidate Adjuvants in a Parenteral Formulation: Cephradine for Injection. J. Pharm. Sci. 1973; 62(9)1543–1545
   PubMed Web of Science ®Google Scholar
• Angberg M., Nyström C., Cartensson S. Evaluation of Heat-Conduction Microcalorimetry in Pharmaceutical Stability Studies. III. Crystallographic Changes Due to Water Vapor Uptake in Anhydrous Lactose Powder. Int. J. Pharm. 1991; 73: 209–220
   Google Scholar
• Angberg M., Nyström C., Cartensson S. Evaluation of Heat-Conduction Microcalorimetry in Pharmaceutical Stability Studies. V. A New Approach for Continuous Measurements in Abundant Water Vapor. Int. J. Pharm. 1992; 81: 153–167
   Web of Science ®Google Scholar
• A. Wade, P.J. WellerLactose Monograph. Handbook of Pharmaceutical Excipients, . American Pharmaceutical Association/The Pharmaceutical Press, Washington, DC/London 1994; Vol. 2: 252–261
   Google Scholar
• Eyljolfsson R. Lisinopril–Lactose Incompatibility. Drug Dev. Ind. Pharm. 1998; 24(8)797–798
   PubMed Web of Science ®Google Scholar
• Sebhatu T., Angberg M., Ahlneck C. Assessment of the Degree of Disorder in Crystalline Solids by Isothermal Microcalorimetry. Int. J. Pharm. 1994; 104: 135–144
   Web of Science ®Google Scholar
• Hüttenrauch R. Fundamentals of Pharmaceutics. Acta Pharm. Technol. 1988; 34(1)1–10
   Web of Science ®Google Scholar